📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE 02 oesophageal cancer trial (2018)

First Author: Davarzani N

Attributed to: CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/his.13491

PubMed Identifier: 29465751

Publication URI: http://europepmc.org/abstract/MED/29465751

Type: Journal Article/Review

Parent Publication: Histopathology

Issue: 7

ISSN: 0309-0167